NECTERO MEDICAL
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
NECTERO MEDICAL
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical Device
Founded:
2017-01-01
Address:
Dover, Delaware, United States
Country:
United States
Website Url:
http://www.necteromedical.com
Total Employee:
11+
Status:
Active
Contact:
866-755-4744
Email Addresses:
[email protected]
Total Funding:
19.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Employees Featured
Investors List
Boston Scientific
Boston Scientific investment in Series C - Nectero Medical
Official Site Inspections
http://www.necteromedical.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nectero Medical"
Nectero Medical – Nectero Medical is developing a novel …
Nectero Medical is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients’ lives.See details»
Company – Nectero Medical
Nectero Medical is led by a highly accomplished, multidisciplinary management team and board of directors with extensive experience in all phases of therapeutic device development. The Nectero Medical team works closely with key …See details»
Nectero Medical - Crunchbase Company Profile
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. Nectero Medical closed a $96 million Series D funding round. View contacts for Nectero Medical to access …See details»
Nectero Medical, Inc. | LinkedIn
Transform Lives by Revolutionizing Treatment of Aneurysmal Disease | Nectero Medical is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease...See details»
Patients – Nectero Medical
Are you or a loved one living with a small to mid-sized abdominal aortic aneurysm (AAA)? The stAAAble Clinical Study may be right for you. Nectero Medical is conducting a clinical trial for the Nectero Endovascular Stabilization Treatment …See details»
Nectero Medical Receives FDA Clearance of IND Application to …
Jul 24, 2023 · The Nectero EAST ® System is a single-use, endovascular system for the treatment of infrarenal abdominal aortic aneurysms and is comprised of a dual-balloon delivery …See details»
Nectero Medical - Overview, News & Similar companies - ZoomInfo
View Nectero Medical (www.necteromedical.com) location in Arizona, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Nectero Medical Receives FDA Clearance of IND Application to …
Jul 24, 2023 · Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients' lives, today announced that the …See details»
Nectero Medical Announces Completion of $96M Series D Financing
TEMPE, Ariz., April 11, 2024 -- (BUSINESS WIRE)-- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today …See details»
Nectero Medical Granted Breakthrough Therapy Designation for …
TEMPE, Ariz., November 01, 2023 -- (BUSINESS WIRE)-- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today …See details»
Nectero Medical Announces Initiation of Phase II/III Clinical Trial of ...
Jan 18, 2024 · TEMPE, Ariz.– (BUSINESS WIRE)–Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve …See details»
Nectero Medical Receives FDA Fast Track Designation for
Aug 24, 2023 · Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, today announced that the U.S. Food and Drug …See details»
Nectero Medical Announces Initiation of Phase II/III Clinical Trial of ...
TEMPE, Ariz., January 18, 2024 -- (BUSINESS WIRE)--Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve …See details»
Nectero Medical Receives FDA Fast Track Designation for Nectero …
Aug 24, 2023 · If successful, the Nectero EAST System may offer patients with smaller AAAs a first approved therapeutic option beyond surveillance. For more information, please visit …See details»
Recent News - Nectero Medical
Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients’ lives, today announced that the U.S. Food and …See details»
Nectero Medical Receives FDA Clearance of IND Application to …
TEMPE, Ariz., July 24, 2023 /PRNewswire/ -- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients' lives, …See details»
Nectero Medical Granted Breakthrough Therapy Designation for …
Nov 1, 2023 · Nectero Medical is initiating a randomized, controlled Phase II/III clinical trial (stAAAble) to evaluate the product’s safety and effectiveness with first subject enrollment …See details»
Nectero Medical Completes $19.5 Million Series C Financing
Sep 10, 2021 · TEMPE, Ariz.-- ( BUSINESS WIRE )-- Nectero Medical Inc. today announced the closing of its $19.5 million Series C financing round, led by new investor Boston Scientific …See details»
Nectero Medical Recognized as a 2024 AZBio Fast Lane Award
TEMPE, Ariz., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced …See details»
News - Nectero Medical
Sep 10, 2021 · Nectero Medical Inc. today announced the closing of its $19.5 million Series C financing round, led by…See details»